Page last updated: 2024-08-18

iodohippuric acid and Prostatic Neoplasms, Castration-Resistant

iodohippuric acid has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bono, P; Fizazi, K; Lietuvietis, V; Massard, C; Nykänen, P; Penttinen, HM; Pohjanjousi, P; Snapir, A; Tammela, TL; Vjaters, E; Vuorela, A1

Trials

1 trial(s) available for iodohippuric acid and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study.
    European urology, 2016, Volume: 69, Issue:5

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Area Under Curve; Capsules; Cross-Over Studies; Disease Progression; Fatigue; Humans; Iodohippuric Acid; Male; Nausea; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Pyrazoles; Tablets

2016